The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents
Article first published online: 15 JUN 2004
Clinical & Experimental Immunology
Volume 137, Issue 1, pages 179–186, July 2004
How to Cite
STRAY-PEDERSEN, A., JÓNSSON, T., HEIBERG, A., LINDMAN, C. R., WIDING, E., AABERGE, I. S., BORRESEN-DALE, A. L. and ABRAHAMSEN, T. G. (2004), The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents. Clinical & Experimental Immunology, 137: 179–186. doi: 10.1111/j.1365-2249.2004.02492.x
- Issue published online: 15 JUN 2004
- Article first published online: 15 JUN 2004
- (Accepted for publication 29 March 2004)
Table S1. Reference values: immunoglobulins. Table S2. Reference values: lymphocyte subsets.
|CEI_2492_sm_tableS1.doc||21K||Supporting info item|
|CEI_2492_sm_tableS2.doc||23K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.